Search filters
Filters
Clear All

Phase

  • 1
  • 5
  • 7
  • 7
  • 4

Found 7 Anemia trials

A listing of Anemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Risks of versus Transfusion in Orthopedic Trauma Patients Anemia

18 - 50
All genders
The purpose of this study is to determine if there is a difference in outcomes between liberal transfusion and conservative transfusion.
Learn More

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease

5 - 45
All genders
The researchers are doing this study to learn if a new type of transplant is safe and effective to treat Severe Sickle Cell Disease (SCD).
Learn More

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease

5 - 45
All genders
We're doing this study to learn if a haploidentical transplant is safe and effective to treat SCD.
Learn More

A study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease using a Reduced-Intensity preparatory regime with Campath-1H Fludarabine and Melphalan

1 - 21
All genders
The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.
Learn More

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (CTRLALT-D)

100 or below
All genders
The primary objective is to estimate and compare overall survival between the two arms:  patients who are Very Likely to find a MUD versus those who are Very Unlikely to find  a MUD.
Learn More

A Phase III International Randomized Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent

18 - 81
All genders
The study's primary objective [in a population of patients with MDS after failure of treatment with azacitidine (AZA) or decitabine (DAC)], is to compare the overall survival (OS) of patients in the rigosertib group vs the Physician's Choice group, in all patients and in a subgroup of patients with IPSS-R …
Learn More

A Study to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

50 - 90
All genders
Phase 3
BAN2401 is an investigational study drug which is being studied in people who have early AD (Alzheimer's disease), with mild cognitive (thinking) impairment or mild dementia. People with AD have a build-up of abnormal protein known as amyloid in their brains.  This build up may lead to impairment in memory …
Learn More